Literature DB >> 19490751

Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation.

Carin Thomas1, Melissa M Mackey, Amy A Diaz, David P Cox.   

Abstract

Mitochondrial dysfunction and reactive oxygen species (ROS) are often implicated in diseases involving oxidative stress and elevated iron. As mitochondria produce ATP by oxidative phosphorylation, ROS by-products are generated from the electron transport chain. Although superoxide and hydrogen peroxide have been thoroughly investigated, little evidence documents hydroxyl radical (HO(*)) production in mitochondria. In order to determine whether HO(*) is generated under oxidative stress conditions by a Fenton-type mechanism, bovine heart submitochondrial particles were examined for HO(*) in the presence and absence of iron ligands, antioxidant enzymes and HO(*) scavengers. HO(*) was measured as 2,3- and 2,5-dihydroxybenzoic acid (DHBA), using HPLC with electrochemical detection. The iron ligand desferrioxamine significantly decreased DHBAs, indicating that HO(*) generation required iron redox-cycling. In addition, results from exogenous SOD and catalase, exogenous hydrogen peroxide, and HO(*)-scavenger studies support a Fenton-type reaction mechanism. The results indicate that increased HO(*) levels occur in mitochondria under oxidative stress and that the HO(*) levels can be modulated with antioxidant enzymes and iron ligands. Our findings together with reports on iron accumulation in degenerative diseases highlight the importance of developing mitochondrial-targeted antioxidants for the therapeutic intervention of diseases associated with mitochondrial dysfunction and oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19490751     DOI: 10.1179/135100009X392566

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  75 in total

Review 1.  Regulation of signal transduction by reactive oxygen species in the cardiovascular system.

Authors:  David I Brown; Kathy K Griendling
Journal:  Circ Res       Date:  2015-01-30       Impact factor: 17.367

2.  Eugenia uniflora leaf essential oil promotes mitochondrial dysfunction in Drosophila melanogaster through the inhibition of oxidative phosphorylation.

Authors:  Nélson R de Carvalho; Nathane R Rodrigues; Giulianna E Macedo; Ivi J Bristot; Aline A Boligon; Marli M de Campos; Francisco A B Cunha; Henrique D Coutinho; Fabio Klamt; Thomas J S Merritt; Thaís Posser; Jeferson L Franco
Journal:  Toxicol Res (Camb)       Date:  2017-05-05       Impact factor: 3.524

Review 3.  Excessive Reactive Oxygen Species and Exotic DNA Lesions as an Exploitable Liability.

Authors:  Safnas F AbdulSalam; Fathima Shazna Thowfeik; Edward J Merino
Journal:  Biochemistry       Date:  2016-09-13       Impact factor: 3.162

4.  Mechanistic Biomarkers in Toxicology

Authors:  Sonia Sanajou; Gönül Şahin
Journal:  Turk J Pharm Sci       Date:  2021-06-18

5.  Hydroxamate-based histone deacetylase inhibitors can protect neurons from oxidative stress via a histone deacetylase-independent catalase-like mechanism.

Authors:  David E Olson; Sama F Sleiman; Megan W Bourassa; Florence F Wagner; Jennifer P Gale; Yan-Ling Zhang; Rajiv R Ratan; Edward B Holson
Journal:  Chem Biol       Date:  2015-04-16

6.  Topical nutraceutical Optixcare EH ameliorates experimental ocular oxidative stress in rats.

Authors:  Peter F Kador; Changmei Guo; Hiroyoshi Kawada; James Randazzo; Karen Blessing
Journal:  J Ocul Pharmacol Ther       Date:  2014-09       Impact factor: 2.671

Review 7.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

Review 8.  Reactive oxygen species: key regulators in vascular health and diseases.

Authors:  Qishan Chen; Qiwen Wang; Jianhua Zhu; Qingzhong Xiao; Li Zhang
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

9.  Dysregulated iron metabolism in the choroid plexus in fragile X-associated tremor/ataxia syndrome.

Authors:  Jeanelle Ariza; Craig Steward; Flora Rueckert; Matt Widdison; Robert Coffman; Atiyeh Afjei; Stephen C Noctor; Randi Hagerman; Paul Hagerman; Verónica Martínez-Cerdeño
Journal:  Brain Res       Date:  2014-12-09       Impact factor: 3.252

10.  Therapeutic Targeting of SDHB-Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid.

Authors:  Yang Liu; Ying Pang; Chunzhang Yang; Karel Pacak; Boqun Zhu; Ondrej Uher; Veronika Caisova; Thanh-Truc Huynh; David Taieb; Katerina Hadrava Vanova; Hans Kumar Ghayee; Jiri Neuzil; Mark Levine
Journal:  Clin Cancer Res       Date:  2020-03-09       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.